SLXN
Silexion Therapeutics Corp
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Under these circumstances, in accordance with the requirements of Accounting Standards Codification (“ASC”) 205-40, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern, as management believes its current funds will be sufficient to fund its operations for only several months from the date these financial statements are issued.”View the 10-Q filed May 15, 2026
Company with tickers: SLXN, SLXNW
Market Cap
$9.29M
Shares Outstanding
3,330,785
CIK
2022416
CUSIP
G1281K130
13F Activity (30d)
2 filings
1 filers
Website
Visit website
Investor Relations
Investor relations
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.